Coronary Stents Market by Product, Material, Deployment, End-User

List of Tables

The Coronary Stents Market was valued at USD 8.44 billion in 2023, expected to reach USD 9.31 billion in 2024, and is projected to grow at a CAGR of 10.48%, to USD 16.95 billion by 2030.

The coronary stents market is integral to cardiovascular health, focusing on devices used to keep coronary arteries open in patients who suffer from coronary artery disease. These stents are primarily metal mesh tubes inserted into an artery after angioplasty to ensure unobstructed blood flow, crucial for preventing cardiac events. The necessity of coronary stents arises from the widespread prevalence of cardiovascular diseases, which are exacerbated by risk factors such as aging population, increasing incidence of lifestyle diseases, and a growing awareness of early diagnosis. The main application is in interventional cardiology, and stents are typically utilized in hospitals, specialty clinics, and cardiac centers. Insights into market growth highlight factors such as technological advancements in stent design, such as bioresorbable stents and drug-eluting stents that offer improved patient outcomes. Furthermore, increasing healthcare expenditure and supportive government policies in developing regions are potent opportunities. However, challenges persist, such as the high cost of procedures, stringent regulatory requirements, and potential complications like restenosis and stent thrombosis. Market growth also faces hurdles in terms of limited access to healthcare in low-income regions and competition from alternative therapies. Areas ripe for innovation include the development of biodegradable stents, improved coating materials for drug delivery, and minimally invasive techniques that enhance the safety and efficacy of stent placement. Businesses should also focus on personalized medicine approaches tailored to individual patient needs, leveraging AI and big data for predictive diagnostics and patient monitoring. The nature of the market remains highly competitive, characterized by rapid technological advances and a strong emphasis on evidence-based enhancements in clinical outcomes. With persistent research and strategic partnerships, companies can capitalize on expanding their portfolio and addressing unmet clinical needs.

KEY MARKET STATISTICS
Base Year [2023]	USD 8.44 billion
Estimated Year [2024]	USD 9.31 billion
Forecast Year [2030]	USD 16.95 billion
CAGR (%)	10.48%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Coronary Stents Market

The Coronary Stents Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

Market Drivers
- Increasing incidences of cardiovascular diseases (CVDs) globally
- Growth in geriatric population
- Acceptance of minimally invasive procedures
Market Restraints
- Availability of alternative treatment in the market
Market Opportunities
- Bioresorbable vascular scaffolds for coronary revascularization
- Advancements in stenting technologies
Market Challenges
- Difficulties and complications with stent implantation

Porter's Five Forces: A Strategic Tool for Navigating the Coronary Stents Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Coronary Stents Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Coronary Stents Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Coronary Stents Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Coronary Stents Market

A detailed market share analysis in the Coronary Stents Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Coronary Stents Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Coronary Stents Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Coronary Stents Market

A strategic analysis of the Coronary Stents Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Coronary Stents Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, B Braun Melsungen AG, Becton, Dickinson and Company, Biosensors International Group, Ltd., Biotronik SE & Co. KG, Boston Scientific Corporation, Cook Medical Incorporated, Elixir Medical Corporation, Integer Holdings Corporation, Johnson & Johnson Services, Inc., Lepu Medical Technology, Medtronic PLC, Meril Life Sciences Private Limited, MicroPort Scientific Corporation, REVA Medical, Inc., Shandong JW Medical Systems LTD., Siemens Healthineers AG, Stentys SA, Terumo Corporation, Translumina GmbH, and Vascular Concepts Limited.

Market Segmentation & Coverage

This research report categorizes the Coronary Stents Market to forecast the revenues and analyze trends in each of the following sub-markets:

Based on Product, market is studied across Bare Metal Stents, Bioresorbable Vascular Scaffold, and Drug Eluting Stents. The Drug Eluting Stents is further studied across Biodegradable and Non-Biodegradable.
Based on Material, market is studied across Copolymer, Metal, and Polymer. The Metal is further studied across CoCr, Nitinol, Stainless, and Steel.
Based on Deployment, market is studied across Balloon-Expandable and Self-Expandable.
Based on End-User, market is studied across Ambulatory Surgery Centers, Cardiology Center, and Hospital.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-A339DAEFA3E2

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing incidences of cardiovascular diseases (CVDs) globally
  - 5.1.1.2. Growth in geriatric population
  - 5.1.1.3. Acceptance of minimally invasive procedures
- 5.1.2. Restraints
  - 5.1.2.1. Availability of alternative treatment in the market
- 5.1.3. Opportunities
  - 5.1.3.1. Bioresorbable vascular scaffolds for coronary revascularization
  - 5.1.3.2. Advancements in stenting technologies
- 5.1.4. Challenges
  - 5.1.4.1. Difficulties and complications with stent implantation
5.2. Market Segmentation Analysis
5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental

6. Coronary Stents Market, by Product

6.1. Introduction
6.2. Bare Metal Stents
6.3. Bioresorbable Vascular Scaffold
6.4. Drug Eluting Stents
- 6.4.1. Biodegradable
- 6.4.2. Non-Biodegradable

7. Coronary Stents Market, by Material

7.1. Introduction
7.2. Copolymer
7.3. Metal
- 7.3.1. CoCr
- 7.3.2. Nitinol
- 7.3.3. Stainless
- 7.3.4. Steel
7.4. Polymer

8. Coronary Stents Market, by Deployment

8.1. Introduction
8.2. Balloon-Expandable
8.3. Self-Expandable

9. Coronary Stents Market, by End-User

9.1. Introduction
9.2. Ambulatory Surgery Centers
9.3. Cardiology Center
9.4. Hospital

10. Americas Coronary Stents Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Coronary Stents Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Coronary Stents Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation

Companies Mentioned

1. Abbott Laboratories
2. B Braun Melsungen AG
3. Becton, Dickinson and Company
4. Biosensors International Group, Ltd.
5. Biotronik SE & Co. KG
6. Boston Scientific Corporation
7. Cook Medical Incorporated
8. Elixir Medical Corporation
9. Integer Holdings Corporation
10. Johnson & Johnson Services, Inc.
11. Lepu Medical Technology
12. Medtronic PLC
13. Meril Life Sciences Private Limited
14. MicroPort Scientific Corporation
15. REVA Medical, Inc.
16. Shandong JW Medical Systems LTD.
17. Siemens Healthineers AG
18. Stentys SA
19. Terumo Corporation
20. Translumina GmbH
21. Vascular Concepts Limited